Filed by Trimeris, Inc. Pursuant to Rule 425 under the Securities Act of 1933 (the Securities...
Synageva BioPharma Corp. (“Synageva”), and Trimeris, Inc. (NASDAQ: TRMS) (“Trimeris”), announced today that each company will...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESS Effective Date: October 12, 2011 Form:...
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-175512 ...
Table of Contents As filed with the Securities and Exchange Commission on October 12, 2011...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934...
Table of Contents As filed with the Securities and Exchange Commission on September 27, 2011 Registration...
Table of Contents As filed with the Securities and Exchange Commission on September 15, 2011 Registration...
Filed by Trimeris, Inc. Pursuant to Rule 425 under the Securities Act of 1933 (the Securities Act) and deemed filed pursuant to...
Filed by Trimeris, Inc. Pursuant to Rule 425 under the Securities Act of 1933 (the ''Securities Act...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.